Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dividend investing for retirement -- Ignore unavailable to you. Want to Upgrade?

To: LTBH who wrote (25867)	11/3/2016 3:28:53 PM
From: JSB	Read Replies (2) \| Respond to of 34328

I saw nothing to explain the punishment of the last few days. A complete mystery to me. Hit the headline number, just light on income and S&P maintains a buy rating but lowers pt to 16 bucks. Anything dividend paying has pretty much been trashed over the last few weeks. At this rate by the time the Fed actually raises that quarter point all these stocks will be near zero.

To: LTBH who wrote (25867)	11/3/2016 3:44:40 PM
From: Steve Felix	Respond to of 34328

Haven't heard the call yet, but specific to MPW, ADPT looks like the "cockroach". A $70 stock in May, now under $9. Unless there is something else, seems overdone, but wdik. S&P CAPITAL IQ KEEPS BUY OPINION ON MEDICAL PROPERTIES TRUST SHARES 11:37 am ET November 3, 2016 (S&P Capital IQ) Print We lower our 12-month target price by $1 to $16 applying a forward price/FFO multiple of 11.8X, a discount to the healthcare REIT average at 12.6X. We reduce our 2016 FFO estimate by $0.03 to $1.27 and raise 2017 by $0.02 to $1.35. MPW posts Q3 FFO of $0.30, vs. $0.32, in line with consensus. MPW's revenue is 61.5% tied to general acute care hospitals, long-term acute hospitals (9.2%) and inpatient rehab hospitals (9.2). Adeptus Health, a smaller operator with liquidity issues, are only 6% of MPW's total 2017 estimated revenue that MPW may consider replacing with a new operator. MPW: 2017 guidance is introduced, with normalized FFO expected to be $1.35-$1.40 per share. 11/03/2016 10:55:33 Bought 55 MPW @ 11.84 -651.20 11/03/2016 10:49:47 Bought 145 MPW @ 11.84 -1,724.80